Zymeworks is a royalty-driven biotechnology company managing a portfolio of healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases
Zymeworks is a royalty-driven biotechnology company managing a portfolio of healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases.